SCHEMBL23309730

SCHEMBL23309730

O=C(Nc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1)c1cc(F)nc(F)c1F

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ LMNA P02545 2/20 0.44
▸ RAB9A P51151 6/20 0.43
▸ NPC1 O15118 5/20 0.43
▸ HTT P42858 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ P2RX1 P51575 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ SNCA P37840 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309621 0.92 RAB9A (0.50) KMT2AMEN1LMNARAB9ANPC1
SCHEMBL23309708 0.92 RAB9A (0.52) KMT2ALMNARAB9ANPC1HTT
SCHEMBL23309490 0.92 GAA (0.51) KMT2AMEN1TDP1LMNARAB9A
SCHEMBL23309555 0.91 HTT (0.55) RAB9ANPC1HTTMAPK1KDM4E
SCHEMBL23309703 0.89 RAB9A (0.51) KMT2AMEN1LMNARAB9ANPC1
SCHEMBL23309714 0.89 POLB (0.51) LMNARAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL23309514 0.89 TRPV1 (0.50) KMT2AMEN1RAB9ANPC1HTT
SCHEMBL23309521 0.89 GRM5 (0.51) KMT2AMEN1LMNARAB9ANPC1
SCHEMBL23309617 0.89 NPC1 (0.54) KMT2AMEN1LMNARAB9ANPC1
SCHEMBL23309483 0.87 CYP1A2 (0.52) KMT2AMEN1RAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL KMT2A 2360/4885MEN1 1633/4885TDP1 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback